HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patricia Cooper Selected Research

ICT2588

4/2014Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patricia Cooper Research Topics

Disease

2Neoplasms (Cancer)
04/2014 - 04/2011
1Gastroesophageal Reflux (GERD)
01/2022
1Glioma (Gliomas)
04/2011
1Brain Neoplasms (Brain Tumor)
04/2011
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2002
1Dyspepsia (Indigestion)
12/2002

Drug/Important Bio-Agent (IBA)

2Peptides (Polypeptides)IBA
04/2014 - 04/2011
1ICT2588IBA
04/2014
1Indicators and Reagents (Reagents)IBA
04/2014
1ProdrugsIBA
04/2014
1von Willebrand FactorIBA
04/2014
1FullerenesIBA
04/2011
1Contrast MediaIBA
04/2011
1hydroxide ionIBA
04/2011
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
04/2011
1Interleukin-13IBA
04/2011
1GadoliniumIBA
04/2011
1GD3 ganglioside (GD(3))IBA
04/2011

Therapy/Procedure

2Therapeutics
04/2014 - 04/2011
1Lasers (Laser)
01/2022
1Hypnosis (Mesmerism)
12/2002